Abbott: One Size Does Not Fit All: The Future of Clinical Trials finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Abbott (NYSE: ABT) today announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the .
AbbottNew efforts focus on research infrastructure, continued training of diverse clinical research personnel and improved diversity within Abbott's own clinical trialsAbbott's Diversity in Clinical Trials
SCOTTSDALE, Ariz. and Needham, Mass. (PRWEB) January 27, 2022 Matrix Clinical Trials, a Matrix Medical Network® (Matrix) business, and Cambridge Healthtech